<?xml version="1.0" encoding="UTF-8"?>
<fig id="pntd.0006530.g003" orientation="portrait" position="float">
 <object-id pub-id-type="doi">10.1371/journal.pntd.0006530.g003</object-id>
 <label>Fig 3</label>
 <caption>
  <title>Cellular immune responses, Lagos, Nigeria.</title>
  <p>PBMC samples from the EVD survivors, documented EVD contacts, and control HCWs were treated with the LFn-EBOV fusion proteins and the IFN-γ+ and TNF-α+ cellular responses were detected by LFn ELISPOT ex vivo experiments. Representative image of IFN-γ (A) and TNF-α (B) cellular responses when stimulated with the LFn-Ebola virus fusion proteins. NP, LFn-EBOV-NP. VP40, LFn-EBOV-VP40. GP1, LFn-EBOV-GP1. LFn, negative control. PHA, phytohemaglutanin, positive control.</p>
 </caption>
 <graphic xlink:href="pntd.0006530.g003" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
